AUBURN, USA, Oct. 28, 2016 The Volpi Group today announced that its U.S. branch has earned ISO 13485 certification. The certification demonstrates that Volpi USA has met the highest international standard for quality management systems used in the design and manufacture of medical devices. Volpi USA’s ISO 13485 certification complements the same accreditation achieved by its Swiss
Read MoreSCHLIEREN, Switzerland, Feb. 8, 2016 The Volpi Group, a 60-year-old optical electronics firm based in Schlieren, Switzerland, today announced that it is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide
Read MoreThe UN General Assembly proclaimed 2015 as the International Year of Light and Light-based Technologies (IYL 2015). The International Year of Light is a global initiative which will highlight to the citizens of the world the importance of light and optical technologies in their lives, for their futures, and for the development of society. It
Read MoreBillerica, Massachusetts and Auburn, New York, USA – November 3rd, 2014 Seahorse Bioscience Inc. and Volpi USA Inc., a subsidiary of the Swiss headquartered Volpi Group liaises for the development and manufacturing of optical modules for the Seahorse XFe Extracellular Flux Analyzer. The XF instruments analyze mitochondrial respiration and glycolysis in live cells, generating data
Read MoreU.S. Representative Dan Maffei, Bio/Med Leaders discuss ways to address job creation, manufacturing/R&D leadership at the Auburn manufacturing facility of New York-based Volpi. > For full Report see Newsroom of the MedTech Association Press contact:Thomas TrachslerDirector Program Management+41 44 732 43 43trachsler@volpi.ch
Read MoreIn the course of the successful evolution Volpi USA has started a class 5 clean-room production at the site in Auburn, New York for the assembly of optical modules for American key account in the Life Science Tools and In Vitro Diagnostics markets. Press contact:Thomas TrachslerDirector Program Management+41 44 732 43 43trachsler@volpi.ch
Read More